ABC | Volume 113, Nº3, Setembro 2019

Artigo Original Dracoulakis et al. Alta atividade plaquetária em uso de AAS na SCA Arq Bras Cardiol. 2019; 113(3):357-363 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 14. Gori AM, Grifoni E, Valenti R, Giusti B, Paniccia R, Parodi G, et al. High on- aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI. Eur J Intern Med. 2016 May;30:49-54. 15. Hobikoglu GF, Norgaz T, Aksu H, Ozer O, ErturkM, NurkalemZ, et al. High frequency of aspirin resistance in patients with acute coronary syndrome. Tohoku J Exp Med. 2005;207(1):59-64. 16. Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012;18(11):1478-93. 17. Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost. 2010;103(1):71-82. 18. BuyukasikY,KarakusS,GokerH,HaznedarogluIC,OzatliD,SayinalpN,etal. RationaluseofthePFA-100device forscreeningofplateletfunctiondisorders and vonWillebrand disease. BloodCoagul Fibrinolysis. 2002;13(4):349-53. 19. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007;28(14):1702-8. 20. Ivandic BT, Giannitsis E, Schlick P, Staritz P, Katus HA, Hohlfeld T. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem. 2007;53(4):614-9. 21. Hobikoglu GF, Norgaz T, Aksu H, Ozer O, Erturk M, Destegul E, et al. The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy. Can J Cardiol. 2007;23(3):201-6. 22. Neubauer H, Kaiser AF, Endres HG, Krüger JC, Engelhardt A, Lask S, et al. Tailoredantiplatelettherapycanovercomeclopidogrelandaspirinresistance – the Bochum clopidogrel and aspirin plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011 Jan;9:3. 23. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991;17(4):433-8. 24. Gola ń ski J, Chłopicki S, Gola ń ski R, Gresner P, Iwaszkiewicz A, Watala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on themonitoring of aspirin antiplatelet therapy. Ther Drug Monit. 2005;27(4):484-90. 25. Rocca B, Santilli F, Pitocco D, Mucci L, Petrucci G, Vitacolonna E, et al. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost. 2012;10(7):1220-30. 26. Dillinger JG, Drissa A, Sideris G, Bal dit Sollier C, Voicu S, Silberman SM, et al. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease. AmHeart J. 2012;164(4):600-6.e1. 27. Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low- dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010; 376(9748):1233-43. 28. Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, et al. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. Thromb Haemost. 2010;104(6):1193-200. 29. Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic Risk Progression (TRIP) Study. Platelets. 2010;21(5):360-7. 30. Ziegler S, Alt E, Brunner M, Speiser W, Minar E. Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100. Semin Thromb Hemost. 2005;31(4):416-9. 363